Výsledky vyhledávání - "Siew-Eng Lim"

Akademický článek

Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients?

Autor: Nakul Saxena, Mikael Hartman, Cheng-Har Yip, Nirmala Bhoo-Pathy, Lay Wai Khin, Nur Aishah Taib, Lai-Meng Looi, Siew-Eng Lim, Soo-Chin Lee, Helena M Verkooijen

Publikováno v: PLoS ONE, Vol 7, Iss 9, p e45809 (2012)

INTRODUCTION: Lymph node ratio (LNR, i.e. the ratio of the number of positive nodes to the total number of nodes excised) is reported to be superior to the absolute number of nodes involved (pN stage) in classifying patients at high versus low risk o

Externí odkaz: https://doaj.org/article/bd03ba36b416451ba520293f7e1cce2b

Zobrazit plný text záznamu

Akademický článek

Ethnic differences in survival after breast cancer in South East Asia.

Autor: Nirmala Bhoo-Pathy, Mikael Hartman, Cheng-Har Yip, Nakul Saxena, Nur Aishah Taib, Siew-Eng Lim, Philip Iau, Hans-Olov Adami, Awang M Bulgiba, Soo-Chin Lee, Helena M Verkooijen

Publikováno v: PLoS ONE, Vol 7, Iss 2, p e30995 (2012)

BACKGROUND: The burden of breast cancer in Asia is escalating. We evaluated the impact of ethnicity on survival after breast cancer in the multi-ethnic region of South East Asia. METHODOLOGY/PRINCIPAL FINDINGS: Using the Singapore-Malaysia hospital-b

Externí odkaz: https://doaj.org/article/189fb1b08f644a69aa9130ea38537d75

Zobrazit plný text záznamu

Akademický článek

Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

IntroductionMolecular profiling of metastatic breast cancer (MBC) through the widespread use of next-generation sequencing (NGS) has highlighted actionable mutations and driven trials of targeted therapy matched to tumour molecular profiles, with imp

Externí odkaz: https://doaj.org/article/98dbdbab3f7349b688320adc069900de

Zobrazit plný text záznamu

Akademický článek

Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia

Autor: Jia Li Low, Elaine Lim, Lavina Bharwani, Andrea Wong, Karmen Wong, Samuel Ow, Siew Eng Lim, Matilda Lee, Joan Choo, Joline Lim, Gloria Chan, Robert John Walsh, Vaishnavi Muthu, Natalie Ngoi, Wanqin Chong, Sing Huang Tan, Soo Chin Lee

Publikováno v: Therapeutic Advances in Medical Oncology, Vol 14 (2022)

Background: Oestrogen receptor positive, human epidermal growth factor receptor-2 (HER2) negative breast cancer (BC) is the most frequently diagnosed BC subtype. Combinations of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) with anti-oestrogen the

Externí odkaz: https://doaj.org/article/e7fedfe987e74365b96a9e8c0c6b25b7

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání